Meet us at the ASGCT's 25th Annual Meeting

The American Society of Gene and Cell Therapy’s (ASGCT) Annual Meeting, celebrating its 25th year in 2022, is the premier event for professionals in gene and cell therapy

Join us at booth 252 to learn more about our 16 years of experience in lentiviral vectors manufacturing

May 16-19 2022
8 am - 8 pm
Washington D.C
Booth 252

Schedule an individual meeting

Book your time slot to discuss your project and to offer our tailor-made support.

Listen to our experts

Poster Presentation : Gene Targeting & Gene Correction III

Christine Duthoit, Cell engineering & Immunology Project Leader, will present the poster abstract on the use of LentiFlash® for clinical applications :

Extensive use of genome editing tools has revealed a great deal of unpredictability, both off- and on-target, in the outcome of their application. Discover how LentiFlash®, Flash Therapeutics' RNA delivery technology, provides efficient gene editing without cell toxicity, while preserving cell phenotype and stem cell differentiation capacity, and with a very low impact on genotoxicity, enhancing the potential of LentiFlash® particles for clinical gene therapy applications.

  • Session Date : May 18, 5:30pm
  • Poster Board Number : W-85
  • Room : Hall D
  • Final Abstract Number : 959

Poster Presentation : RNA virus vectors

Régis Gayon, Vectorology & Cell engineering Manager, will present the poster abstract on efficient and safe delivery of multiple mRNA using non-integrative Bacteriophage-chimeric Retrovirus-like particles for in vivo applications.

  • Session Date : May 18, 5:30pm
  • Poster Board Number : W-12
  • Room : Hall D
  • Final Abstract Number : 886
Congress booth